Design and Evaluation of Engineered Extracellular Vesicle (EV)-Based Targeting for EGFR-Overexpressing Tumor Cells Using Monobody Display.
Komuro H, Aminova S, Lauro K, Woldring D, Harada M
Bioengineering (Basel). 2022 Jan 29;9(2). pii: bioengineering9020056. doi: 10.3390/bioengineering9020056.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 200162 | pcS-E626-C1C2 | This plasmid encodes EGFR targeting monobody (E626) fused to the extracellular vesicle binding domain (C1C2) of lactadherin for surface engineering extracellular vesicles. |
| 200163 | pcS-RDG-C1C2 | This plasmid encodes non-binder control monobody (RDG) fused to the extracellular vesicle binding domain (C1C2) of lactadherin for surface engineering extracellular vesicles. |